Federal Register Notice: FDA is announcing an opportunity for a hearing on a proposal to revoke a biologics license issued to Allergy Laboratories, Inc. for manufacturing nonstandardized allergenic extract dust, house mixture. The proposed revocation is based on available scientific and medical information that does not support the safety and effectiveness of this nonstandardized allergenic extract. To view this notice, click here.
